Olema Pharmaceuticals, Inc. Quarterly Return On Equity in % from Q4 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Olema Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2020 to Q3 2024.
  • Olema Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2024 was -53.6 %, a 12.8% decline year-over-year.
  • Olema Pharmaceuticals, Inc. annual Return On Equity for 2023 was -44.7 %, a 2.32% increase from 2022.
  • Olema Pharmaceuticals, Inc. annual Return On Equity for 2022 was -45.7 %, a 97.1% decline from 2021.
  • Olema Pharmaceuticals, Inc. annual Return On Equity for 2021 was -23.2 %, a 24.1% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -53.6 -6.07 -12.8% Jul 1, 2024 Sep 30, 2024
Q2 2024 -44.2 +7.58 +14.6% Apr 1, 2024 Jun 30, 2024
Q1 2024 -42.9 +10.4 +19.5% Jan 1, 2024 Mar 31, 2024
Q4 2023 -44.7 +1.06 +2.32% Oct 1, 2023 Dec 31, 2023
Q3 2023 -47.5 -7.53 -18.8% Jul 1, 2023 Sep 30, 2023
Q2 2023 -51.8 -16.7 -47.7% Apr 1, 2023 Jun 30, 2023
Q1 2023 -53.3 -26.2 -96.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 -45.7 -22.5 -97.1% Oct 1, 2022 Dec 31, 2022
Q3 2022 -40 -21.3 -114% Jul 1, 2022 Sep 30, 2022
Q2 2022 -35.1 -14.2 -68.4% Apr 1, 2022 Jun 30, 2022
Q1 2022 -27.1 -4.25 -18.6% Jan 1, 2022 Mar 31, 2022
Q4 2021 -23.2 +7.35 +24.1% Oct 1, 2021 Dec 31, 2021
Q3 2021 -18.6 Jul 1, 2021 Sep 30, 2021
Q2 2021 -20.8 Apr 1, 2021 Jun 30, 2021
Q1 2021 -22.8 Jan 1, 2021 Mar 31, 2021
Q4 2020 -30.6 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.